Barbara E. Kream

7.5k total citations · 2 hit papers
102 papers, 6.0k citations indexed

About

Barbara E. Kream is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Barbara E. Kream has authored 102 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 39 papers in Genetics and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Barbara E. Kream's work include Bone Metabolism and Diseases (26 papers), Bone health and treatments (22 papers) and Growth Hormone and Insulin-like Growth Factors (19 papers). Barbara E. Kream is often cited by papers focused on Bone Metabolism and Diseases (26 papers), Bone health and treatments (22 papers) and Growth Hormone and Insulin-like Growth Factors (19 papers). Barbara E. Kream collaborates with scholars based in United States, Australia and Netherlands. Barbara E. Kream's co-authors include Lawrence G. Raisz, David W. Rowe, Hector F. DeLuca, John A. Eisman, John Harrison, Alexander C. Lichtler, Alan J. Hamstra, Donna N. Petersen, Ernesto Canalis and Marja M. Hurley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Barbara E. Kream

101 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Construction of DNA sequences complementary to rat .alpha.1 and .alpha.2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D

1984 556 citations David W. Rowe, Barbara E. Kream et al. Biochemistry profile →
A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma

1976 458 citations John A. Eisman, Barbara E. Kream et al. Archives of Biochemistry and Biophysics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara E. Kream United States	41	3.1k	1.4k	1.3k	1.1k	1.0k	102	6.0k
Yoshiki Seino Japan	39	1.9k 0.6×	751 0.5×	1.4k 1.1×	1.4k 1.3×	1.3k 1.2×	238	6.0k
Paula H. Stern United States	37	1.9k 0.6×	1.4k 1.0×	566 0.4×	775 0.7×	664 0.7×	163	4.4k
Sohei Kitazawa Japan	47	3.5k 1.1×	1.8k 1.3×	722 0.6×	691 0.6×	614 0.6×	261	7.0k
Dengshun Miao China	46	3.6k 1.2×	1.7k 1.2×	1.1k 0.9×	1.8k 1.6×	556 0.5×	195	7.7k
Arthur E. Broadus United States	44	2.6k 0.8×	3.1k 2.2×	789 0.6×	717 0.6×	663 0.7×	93	6.8k
Hiroshi Kaji Japan	48	3.0k 1.0×	1.7k 1.2×	633 0.5×	529 0.5×	688 0.7×	228	6.8k
Shusaku Yoshiki Japan	31	6.1k 2.0×	2.7k 1.9×	1.2k 0.9×	942 0.8×	531 0.5×	77	9.8k
Stavroula Kousteni United States	36	3.5k 1.1×	1.9k 1.4×	1.5k 1.1×	428 0.4×	782 0.8×	62	6.6k
Riko Kitazawa Japan	39	2.7k 0.9×	1.5k 1.1×	720 0.6×	598 0.5×	579 0.6×	230	5.6k
Toshimi Michigami Japan	41	1.8k 0.6×	1.4k 1.0×	854 0.7×	608 0.5×	783 0.8×	152	4.6k

Countries citing papers authored by Barbara E. Kream

Since Specialization

Citations

This map shows the geographic impact of Barbara E. Kream's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara E. Kream with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara E. Kream more than expected).

Fields of papers citing papers by Barbara E. Kream

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara E. Kream. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara E. Kream. The network helps show where Barbara E. Kream may publish in the future.

Co-authorship network of co-authors of Barbara E. Kream

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara E. Kream. A scholar is included among the top collaborators of Barbara E. Kream based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara E. Kream. Barbara E. Kream is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tok, Melissa N. van, Nataliya Yeremenko, Christine A. Teitsma, et al.. (2016). Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis. PLoS ONE. 11(10). e0163632–e0163632. 1 indexed citations

Cao, Jay, Guomin Ou, Nianlan Yang, et al.. (2015). Impact of targeted PPARγ disruption on bone remodeling. Molecular and Cellular Endocrinology. 410. 27–34. 35 indexed citations

Ben‐Sasson, Shlomo Z., Hongli Dong, Barbara E. Kream, et al.. (2010). PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER. PLoS ONE. 5(8). e12011–e12011. 57 indexed citations

Gao, Qi, Cynthia Alander, Barbara E. Kream, et al.. (2009). Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice. Bone. 45(1). 98–103. 16 indexed citations

Yang, Maobin & Barbara E. Kream. (2008). Calcitonin induces expression of the inducible cAMP early repressor in osteoclasts. Endocrine. 33(3). 245–253. 11 indexed citations

Liu, Fei, Sun‐Kyeong Lee, Douglas J. Adams, Gloria Gronowicz, & Barbara E. Kream. (2007). CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment. Bone. 40(4). 1135–1143. 26 indexed citations

Jiang, Jin, Alexander C. Lichtler, Gloria Gronowicz, et al.. (2006). Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone. 39(3). 494–504. 81 indexed citations

Shultz, Kathryn L., Gloria Gronowicz, Boguslawa Koczon-Jaremko, et al.. (2006). Congenic Mice Provide in Vivo Evidence for a Genetic Locus that Modulates Serum Insulin-Like Growth Factor-I and Bone Acquisition. Endocrinology. 147(8). 3915–3923. 33 indexed citations

He, Jianing, Clifford J. Rosen, Douglas J. Adams, & Barbara E. Kream. (2006). Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone. 38(6). 826–835. 64 indexed citations

10.

Huang, Yingqun, et al.. (2005). Identification of Novel cAMP Responsive Element Modulator (CREM) Isoforms Expressed by Osteoblasts. Calcified Tissue International. 77(2). 91–95. 6 indexed citations

11.

Dodig, Milan, Mark S. Kronenberg, Antonio Bedalov, et al.. (1996). Identification of a TAAT-containing Motif Required for High Level Expression of the Promoter in Differentiated Osteoblasts of Transgenic Mice. Journal of Biological Chemistry. 271(27). 16422–16429. 78 indexed citations

12.

Bedalov, Antonio, David T. Breault, Boris P. Sokolov, et al.. (1994). Regulation of the alpha 1(I) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells.. Journal of Biological Chemistry. 269(7). 4903–4909. 35 indexed citations

13.

Krebsbach, Paul H., John Harrison, Alexander C. Lichtler, et al.. (1993). Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells.. Molecular and Cellular Biology. 13(9). 5168–5174. 57 indexed citations

14.

Harrison, John, Sofía Vargas, Donna N. Petersen, Joseph A. Lorenzo, & Barbara E. Kream. (1990). Interleukin-1α and Phorbol Ester Inhibit Collagen Synthesis in Osteoblastic MC3T3-E1 Cells by a Transcriptional Mechanism. Molecular Endocrinology. 4(2). 184–190. 30 indexed citations

15.

Lichtler, Alexander C., et al.. (1989). Isolation and characterization of the rat α1(I) collagen promoter. Journal of Biological Chemistry. 264(6). 3072–3077. 125 indexed citations

16.

Harrison, John, et al.. (1989). 1,25-Dihydroxyvitamin D₃Inhibits Transcription of Type I Collagen Genes in the Rat Osteosarcoma Cell Line ROS 17/2.8*. Endocrinology. 125(1). 327–333. 67 indexed citations

17.

Rowe, David W., et al.. (1984). Construction of DNA sequences complementary to rat .alpha.1 and .alpha.2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry. 23(25). 6210–6216. 556 indexed citations breakdown →

18.

Rowe, David W. & Barbara E. Kream. (1982). Regulation of collagen synthesis in fetal rat calvaria by 1,25-dihydroxyvitamin D3.. Journal of Biological Chemistry. 257(14). 8009–8015. 114 indexed citations

19.

Ghazarian, Jacob G., Barbara E. Kream, Kathleen M. Botham, M W Nickells, & Hector F. DeLuca. (1978). Rat plasma 25-hydroxyvitamin D3 binding protein: An inhibitor of the 25-hydroxyvitamin D3-1 α-hydroxylase. Archives of Biochemistry and Biophysics. 189(1). 212–220. 26 indexed citations

20.

Kream, Barbara E., Robert D. Reynolds, Joyce C. Knutson, John A. Eisman, & Hector F. DeLuca. (1976). Intestinal cytosol binders of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3. Archives of Biochemistry and Biophysics. 176(2). 779–787. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact